← Back to declarations

AMGN Amgen Inc. — dividend yield, history & ex-dividend dates

NASDAQ Global Select· Quarterly dividend· Common Stock · Healthcare / Drug Manufacturers - General

$377.35 ▼ $-5.12(-1.34%) as of Sep 14, 2026 03:06 UTC
Sponsored Advanced charts & data →

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Ad

Dividend Snapshot

StatusGrowing
Latest Dividend$2.5200
Forward Annual$10.08
FrequencyQuarterly
Last Ex-DateAug 21, 2026
1-Yr Growth5.8%Annual totals, 2024–2025
10-Yr Growth11.7%Annual totals, 2015–2025

Key Metrics

Current Yield

2.67%

At the Sep 14, 2026 price

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$10.0800

The most recent payment scaled to a full year by how often it's paid. A $0.25 quarterly dividend annualizes to $1.00.

Frequency

Q Quarterly

How often the dividend is paid: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

Rank Score

57.7

As of Sep 14, 2026

Our 0-100 house score blending yield quality, payout sustainability (the trailing-twelve-month payout ratio), profitability (TTM return on equity), valuation (TTM price-to-book) and payment reliability, recomputed daily. Higher means a stronger profile on those factors in our model — a research score, not advice or a recommendation to buy.

RSI (14)

31

As of Sep 14, 2026

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$271.18 – $444.12

Closes through Sep 11, 2026

The lowest and highest price over the past year — shows where today's price sits in its recent range.

Payout Ratio (TTM)

60.45%

12 months to Jun 30, 2026 (Q2 FY2026)

The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.

Years Paying

15

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

Price / Book (TTM)

17.43

Price as of Sep 14, 2026; latest reported book value

Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.

S.A.F.E. Dividend Read

S.A.F.E. is our quick durability read on a dividend — the same four-check test used across the screener and our ranked lists. Solid: a model rank of 70+ and a yield of 2%+; the rank weighs the trailing-twelve-month payout ratio, return on equity and price-to-book. Accelerating: the dividend has grown over time, not stalled. Flawless: an unbroken record with no cuts or suspensions. Enduring: a long enough paying history to weather a cycle. All four met earns the S.A.F.E. flag.
S Solid
Below the Solid check (model rank 70+ and yield 2%+): rank 58/100, yield 2.67%.
A Accelerating
14 consecutive years of dividend increases.
F Flawless
No dividend cut in the available payment record.
E Enduring
15 year(s) of payments on record, under the 20 this check looks for.

Quote & Key Data

ExchangeNASDAQ Global SelectThe stock exchange where the shares trade, such as NYSE or Nasdaq.
Volume2,272,400Sep 11, 2026 sessionHow many shares changed hands in the latest session — a rough read on trading activity.
Open$386.14Sep 11, 2026 sessionThe price at the start of the latest trading session.
Day Range$377.22 – $386.99Sep 11, 2026 sessionThe lowest and highest price during the latest trading session.
Prev Close$382.47Close of Sep 10, 2026The closing price from the previous trading session.
Market Cap$203.66BAs of Sep 14, 2026The company's total market value — share price times shares outstanding — on the date shown.
Shares Out539.71MImplied by market cap, Sep 14, 2026Shares outstanding implied by the market cap and share price on the date shown.
EPS (TTM)$16.1912 months to Jun 30, 2026 (Q2 FY2026)Earnings per share over the trailing twelve months (TTM), labeled with the end date of the latest reported quarter and shown in the company's reporting currency. Dividends are paid out of these earnings.
P/E (TTM)23.3Price as of Sep 14, 2026; earnings to Jun 30, 2026Price-to-earnings ratio: the share price on the date shown divided by trailing-twelve-month earnings per share. A rough gauge of how richly the stock is valued.
Ex-DividendAug 21, 2026Buy before this date to receive the upcoming payment. Buy on or after it and the seller keeps that one.
Pay DateSep 11, 2026The date the dividend is actually paid into shareholders' accounts.

Dividend Growth

3-Yr Growth (CAGR)7.1%Annual totals, 2022–2025The dividend's average annual growth rate over the period, compounded. Steady growth signals a healthy, rising payout.
5-Yr Growth (CAGR)8.3%Annual totals, 2020–2025The dividend's average annual growth rate over the period, compounded. Steady growth signals a healthy, rising payout.
Consecutive Increases14 yrsAnnual totals through 2025The number of years in a row the dividend has increased — a track record of reliability.

Why the Yield Moved (90 Days)

AMGN's dividend yield fell from 2.90% to 2.67% over the past ~90 days (-0.23 pp). Of that move, +0.00 pp came from changes in the dividend rate and -0.23 pp from the share price ($347.84 on Jun 16, 2026 → $377.35 on Sep 14, 2026). A yield that rises because the price fell is not an improvement in the payout itself.

Yield vs Its Own History

Current2.67%
1-Yr Average2.86%
Low / High2.27% – 3.63%
Percentile15%

Across 335 daily observations over the past 16 months (through Sep 11, 2026), AMGN's current yield is higher than approximately 15% of them. Our stored price history for AMGN covers the past 16 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$2.5200 Q Regular Jul 30, 2026 Aug 21, 2026 Aug 21, 2026 Sep 11, 2026
$2.5200 Q Regular Mar 04, 2026 May 15, 2026 May 15, 2026 Jun 05, 2026
$2.5200 Q Regular Dec 09, 2025 Feb 13, 2026 Feb 13, 2026 Mar 06, 2026
$2.3800 Q Regular Oct 31, 2025 Nov 21, 2025 Nov 21, 2025 Dec 12, 2025
$2.3800 Q Regular Aug 01, 2025 Aug 22, 2025 Aug 22, 2025 Sep 12, 2025
$2.3800 Q Regular Mar 04, 2025 May 16, 2025 May 16, 2025 Jun 06, 2025
$2.3800 Q Regular Dec 10, 2024 Feb 14, 2025 Feb 14, 2025 Mar 07, 2025
$2.2500 Q Regular Oct 25, 2024 Nov 18, 2024 Nov 18, 2024 Dec 09, 2024
$2.2500 Q Regular Aug 02, 2024 Aug 16, 2024 Aug 16, 2024 Sep 06, 2024
$2.2500 Q Regular Mar 06, 2024 May 16, 2024 May 17, 2024 Jun 07, 2024
$2.2500 Q Regular Dec 12, 2023 Feb 15, 2024 Feb 16, 2024 Mar 07, 2024
$2.1300 Q Regular Oct 24, 2023 Nov 16, 2023 Nov 17, 2023 Dec 08, 2023
$2.1300 Q Regular Aug 01, 2023 Aug 17, 2023 Aug 18, 2023 Sep 08, 2023
$2.1300 Q Regular Mar 07, 2023 May 17, 2023 May 18, 2023 Jun 08, 2023
$2.1300 Q Regular Dec 12, 2022 Feb 14, 2023 Feb 15, 2023 Mar 08, 2023
$1.9400 Q Regular Oct 28, 2022 Nov 16, 2022 Nov 17, 2022 Dec 08, 2022
$1.9400 Q Regular Aug 03, 2022 Aug 17, 2022 Aug 18, 2022 Sep 08, 2022
$1.9400 Q Regular Mar 02, 2022 May 16, 2022 May 17, 2022 Jun 08, 2022
$1.9400 Q Regular Dec 03, 2021 Feb 14, 2022 Feb 15, 2022 Mar 08, 2022
$1.7600 Q Regular Oct 21, 2021 Nov 15, 2021 Nov 16, 2021 Dec 08, 2021
$1.7600 Q Regular Jul 30, 2021 Aug 16, 2021 Aug 17, 2021 Sep 08, 2021
$1.7600 Q Regular Mar 03, 2021 May 14, 2021 May 17, 2021 Jun 08, 2021
$1.7600 Q Regular Dec 16, 2020 Feb 11, 2021 Feb 15, 2021 Mar 08, 2021
$1.6000 Q Regular Oct 21, 2020 Nov 13, 2020 Nov 16, 2020 Dec 08, 2020
$1.6000 Q Regular Jul 23, 2020 Aug 14, 2020 Aug 17, 2020 Sep 08, 2020
$1.6000 Q Regular Mar 04, 2020 May 15, 2020 May 18, 2020 Jun 08, 2020
$1.6000 Q Regular Dec 11, 2019 Feb 13, 2020 Feb 14, 2020 Mar 06, 2020
$1.4500 Q Regular Oct 22, 2019 Nov 14, 2019 Nov 15, 2019 Dec 06, 2019
$1.4500 Q Regular Aug 02, 2019 Aug 14, 2019 Aug 15, 2019 Sep 06, 2019
$1.4500 Q Regular Mar 07, 2019 May 16, 2019 May 17, 2019 Jun 07, 2019
$1.4500 Q Regular Dec 07, 2018 Feb 14, 2019 Feb 15, 2019 Mar 08, 2019
$1.3200 Q Regular Oct 23, 2018 Nov 15, 2018 Nov 16, 2018 Dec 07, 2018
$1.3200 Q Regular Jul 31, 2018 Aug 16, 2018 Aug 17, 2018 Sep 07, 2018
$1.3200 Q Regular Mar 07, 2018 May 16, 2018 May 17, 2018 Jun 08, 2018
$1.3200 Q Regular Dec 12, 2017 Feb 14, 2018 Feb 15, 2018 Mar 08, 2018
$1.1500 Q Regular Oct 24, 2017 Nov 16, 2017 Nov 17, 2017 Dec 08, 2017
$1.1500 Q Regular Jul 31, 2017 Aug 15, 2017 Aug 17, 2017 Sep 08, 2017
$1.1500 Q Regular Mar 08, 2017 May 15, 2017 May 17, 2017 Jun 08, 2017
$1.1500 Q Regular Dec 21, 2016 Feb 13, 2017 Feb 15, 2017 Mar 08, 2017
$1.0000 Q Regular Oct 17, 2016 Nov 14, 2016 Nov 16, 2016 Dec 08, 2016
$1.0000 Q Regular Jul 22, 2016 Aug 15, 2016 Aug 17, 2016 Sep 08, 2016
$1.0000 Q Regular Mar 02, 2016 May 13, 2016 May 17, 2016 Jun 08, 2016
$1.0000 Q Regular Dec 16, 2015 Feb 11, 2016 Feb 16, 2016 Mar 08, 2016
$0.7900 Q Regular Oct 15, 2015 Nov 12, 2015 Nov 16, 2015 Dec 07, 2015
$0.7900 Q Regular Jul 29, 2015 Aug 13, 2015 Aug 17, 2015 Sep 08, 2015
$0.7900 Q Regular Mar 05, 2015 May 12, 2015 May 14, 2015 Jun 05, 2015
$0.7900 Q Regular Dec 18, 2014 Feb 10, 2015 Feb 12, 2015 Mar 06, 2015
$0.6100 Q Regular Oct 17, 2014 Nov 10, 2014 Nov 13, 2014 Dec 05, 2014
$0.6100 Q Regular Jul 25, 2014 Aug 12, 2014 Aug 14, 2014 Sep 05, 2014
$0.6100 Q Regular Mar 05, 2014 May 13, 2014 May 15, 2014 Jun 06, 2014
$0.6100 Q Regular Dec 13, 2013 Feb 11, 2014 Feb 13, 2014 Mar 07, 2014
$0.4700 Q Regular Oct 16, 2013 Nov 12, 2013 Nov 14, 2013 Dec 06, 2013
$0.4700 Q Regular Jul 26, 2013 Aug 14, 2013 Aug 16, 2013 Sep 06, 2013
$0.4700 Q Regular Mar 06, 2013 May 14, 2013 May 16, 2013 Jun 07, 2013
$0.4700 Q Regular Dec 14, 2012 Feb 11, 2013 Feb 13, 2013 Mar 07, 2013
$0.3600 Q Regular Oct 11, 2012 Nov 13, 2012 Nov 15, 2012 Dec 07, 2012
$0.3600 Q Regular Jul 19, 2012 Aug 14, 2012 Aug 16, 2012 Sep 07, 2012
$0.3600 Q Regular Mar 15, 2012 May 14, 2012 May 16, 2012 Jun 07, 2012
$0.3600 Q Regular Dec 16, 2011 Feb 13, 2012 Feb 15, 2012 Mar 07, 2012
$0.2800 Q Regular Oct 13, 2011 Nov 15, 2011 Nov 17, 2011 Dec 08, 2011
$0.2800 Q Regular Jul 29, 2011 Aug 16, 2011 Aug 18, 2011 Sep 08, 2011

Peer Comparison

Selected Drug Manufacturers - General dividend payers we cover, strongest DividendRank first — for context, not a recommendation.

TickerNameYield5-Yr GrowthStreakRank
ALPMF Astellas Pharma Inc. 3.27% 4.0% 0 yrs 76
BMY Bristol-Myers Squibb Company 3.96% 1.6% 4 yrs 75
ALPMY Astellas Pharma Inc. 3.53% 5.6% 10 yrs 72
OPHLF Ono Pharmaceutical Co., Ltd. 3.45% 0.4% 0 yrs 69

AMGN dividend — frequently asked questions

Does Amgen Inc. pay a dividend?

Yes. Amgen Inc. (AMGN) currently pays a dividend. The annualized dividend is about $10.08 per share, a yield of approximately 2.67%.

What is Amgen Inc.'s dividend yield?

Amgen Inc.'s dividend yield is approximately 2.67%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.

How often does Amgen Inc. pay dividends?

Amgen Inc. pays dividends quarterly — 4 times per year.

How long has Amgen Inc. paid dividends?

Amgen Inc. has 15 years of dividend payments on record, and has increased its dividend for 14 consecutive years.

Data updated Sep 14, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.

View
Theme